Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2007-06-29
2011-10-18
Nickol, Gary (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100, C530S350000, C536S023700
Reexamination Certificate
active
08039007
ABSTRACT:
Various specific meningococcal proteins are disclosed. The invention provides related polypeptides, nucleic acids, antibodies and methods. These can all be used in medicine for treating or preventing disease and/or infection caused by meningococcus, such as bacterial meningitis.
REFERENCES:
patent: 7504111 (2009-03-01), Fontana et al.
patent: 2002/0082206 (2002-06-01), Leach et al.
patent: WO0279243 (2002-10-01), None
Houghten et al. (Vaccines, 1986, Edited by Fred Brown: Cold Spring Harbor Laboratory).
Holmes, Exp. Opin.Invest. Drugs, 2001, 10(3):511-519).
Greenspan et al (Nature Biotechnology, 1999, 7:936-937).
Database Geneseq [Online]. “Protein encoded by Prokaryotic essential gene #23450.” XP002467933, retrieved from EBI accession No. GSP:ABU37923, from patent application WO200277, 2007.
Database Geneseq [Online]. “Prokaryotic essential gene #23450.” XP002467934, retrieved from EBI accession No. GSN:ACA41793, from patent application WO200277183, 2007.
Pizza, M. et al. “Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.” Science, 287(5459): 1816-1820 (2000).
Tettelin, H. et al. “Complete genome sequence ofNeisseria meningitidisserogroup B strain MC58.” Science, 287(5459): 1809-1815 (2000).
Parkhill, J. et al. “Complete DNA sequence of a serogroup A strain ofNeisseria meningitidisZ2491.” Nature, 404(6777): 502-506 (2000).
Fraser Claire
Pizza Mariagrazia
Rappuoli Rino
Scarselli Maria
Serruto Davide
Baskar Padma
J. Craig Venter Institute, Inc.
Morrison & Foerster / LLP
Nickol Gary
Novartis AG
LandOfFree
Polypeptides from Neisseria meningitidis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptides from Neisseria meningitidis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptides from Neisseria meningitidis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4298436